Oslo, Norway, October 24, 2022 - Cipriano AS and Cipriano Invest AS, a 100% owned subsidiary of Cipriano AS, have merged. As a result, 1,625,000 shares in Nykode Therapeutics ASA have been transferred from Cipriano Invest AS to Cipriano AS. Cipriano AS is 100% owned by primary insider Einar J. Greve, Deputy Board Member of Nykode Therapeutics ASA. 

Please see further details in attached document.